Premarket Gainer
PSTV Plus Therapeutics2.60+0.32+14.0%
Premarket:3.17+0.57 (+21.9%)
Plus Therapeutics Announces Key RNL Development and cGMP Drug Manufacturing Collaboration Agreements
Globe NewswireTue, 4-May 7:30 AM
Premarket Gainer
PSTV Plus Therapeutics Inc.2.44-0.02-0.8%
Premarket:4.08+1.64 (+67.2%)
Plus Therapeutics Receives Fast Track Designation From FDA for Its Novel Glioblastoma Treatment
Globe NewswireTue, 15-Sep 7:00 AM
Premarket Gainer
PSTV Plus Therapeutics Inc.2.45+0.03+1.2%
Premarket:3.97+1.52 (+62.0%)
Plus Therapeutics, Inc. receives FDA Orphan Drug Designation for its Novel Glioblastoma Treatment
Globe NewswireTue, 1-Sep 7:00 AM
Premarket Gainer
PSTV Plus Therapeutics Inc.1.44+0.01+0.7%
Premarket:2.23+0.79 (+54.9%)
Plus Therapeutics Licenses Novel Oncology Platform, Expands Pipeline
Globe NewswireMon, 30-Mar 7:15 AM
Premarket Gainer
PSTV Plus Therapeutics Inc.2.39-0.12-4.8%
Premarket:3.05+0.66 (+27.6%)
Plus Therapeutics Reports Third Quarter 2019 Financial and Business Results
Globe NewswireThu, 14-Nov 4:05 PM